Mackenzie Financial’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,271
Closed -$322K 1824
2024
Q4
$322K Buy
31,271
+1,434
+5% +$13.9K ﹤0.01% 1354
2024
Q3
$283K Buy
29,837
+7,320
+33% +$63.2K ﹤0.01% 1212
2024
Q2
$192K Buy
+22,517
New +$206K ﹤0.01% 1348
2023
Q4
Sell
-10,577
Closed -$93K 1598
2023
Q3
$93K Hold
10,577
﹤0.01% 1354
2023
Q2
$118K Sell
10,577
-1,700
-14% -$15.1K ﹤0.01% 1396
2023
Q1
$129K Buy
+12,277
New +$135K ﹤0.01% 1388

Other funds holding ENFN

Mackenzie Financial's ENFN Position: Q1 2025 in Review

Mackenzie Financial sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 31,271 shares — an estimated $322K sold.

Mackenzie Financial first reported a position in ENFN in Q1 2023 and held it in 6 quarters. The position peaked at $322K in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Mackenzie Financial reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Mackenzie Financial sold 31,271 Enfusion, Inc. shares in Q1 2025, an estimated $322K.
  • Mackenzie Financial first reported a position in Enfusion, Inc. in Q1 2023 and held it in 6 quarters.
  • Mackenzie Financial's Enfusion, Inc. position peaked at $322K in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Mackenzie Financial's 13F filing for Q1 2025, filed 7 May 2025.